JP2020518645A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020518645A5 JP2020518645A5 JP2019560756A JP2019560756A JP2020518645A5 JP 2020518645 A5 JP2020518645 A5 JP 2020518645A5 JP 2019560756 A JP2019560756 A JP 2019560756A JP 2019560756 A JP2019560756 A JP 2019560756A JP 2020518645 A5 JP2020518645 A5 JP 2020518645A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- composition
- hvr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023080140A JP2023099232A (ja) | 2017-05-05 | 2023-05-15 | 炎症性消化器障害を処置するための方法および組成物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762502480P | 2017-05-05 | 2017-05-05 | |
| US62/502,480 | 2017-05-05 | ||
| US201762572337P | 2017-10-13 | 2017-10-13 | |
| US62/572,337 | 2017-10-13 | ||
| PCT/US2018/031231 WO2018204871A1 (en) | 2017-05-05 | 2018-05-04 | Methods and compositions for treating inflammatory gastrointestinal disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023080140A Division JP2023099232A (ja) | 2017-05-05 | 2023-05-15 | 炎症性消化器障害を処置するための方法および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020518645A JP2020518645A (ja) | 2020-06-25 |
| JP2020518645A5 true JP2020518645A5 (enExample) | 2021-06-17 |
| JP7346304B2 JP7346304B2 (ja) | 2023-09-19 |
Family
ID=64016746
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019560756A Active JP7346304B2 (ja) | 2017-05-05 | 2018-05-04 | 炎症性消化器障害を処置するための方法および組成物 |
| JP2023080140A Pending JP2023099232A (ja) | 2017-05-05 | 2023-05-15 | 炎症性消化器障害を処置するための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023080140A Pending JP2023099232A (ja) | 2017-05-05 | 2023-05-15 | 炎症性消化器障害を処置するための方法および組成物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20200270344A1 (enExample) |
| EP (1) | EP3618872A4 (enExample) |
| JP (2) | JP7346304B2 (enExample) |
| KR (1) | KR20200015511A (enExample) |
| CN (1) | CN111246880A (enExample) |
| AU (1) | AU2018263937A1 (enExample) |
| BR (1) | BR112019022957A2 (enExample) |
| CA (1) | CA3062430A1 (enExample) |
| IL (1) | IL270304B2 (enExample) |
| MX (1) | MX2019013136A (enExample) |
| SG (2) | SG10202112259VA (enExample) |
| WO (1) | WO2018204871A1 (enExample) |
| ZA (1) | ZA201907372B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI634900B (zh) | 2013-07-11 | 2018-09-11 | 再生元醫藥公司 | 藉由投與ｉｌ－４ｒ抑制劑治療嗜酸性食道炎的方法 |
| HK1254432A1 (zh) | 2015-06-17 | 2019-07-19 | Allakos Inc. | 用於治疗纤维性疾病的方法和组合物 |
| BR112019022912A2 (pt) | 2017-05-05 | 2020-05-26 | Allakos Inc. | Métodos e composições para tratar doenças oculares alérgicas |
| CA3087063A1 (en) | 2017-12-29 | 2019-07-04 | Cornell University | Gene therapy for eosinophilic disorders |
| BR112021015009A2 (pt) * | 2019-02-15 | 2021-10-05 | Allakos Inc. | Métodos e composições para o tratamento da gastrite mastocística, esofagite mastocística, enterite mastocística, duodenite mastocística e/ou gastroenterite mastocística |
| MX2022001403A (es) * | 2019-08-02 | 2022-03-25 | Allakos Inc | Metodos de administracion de anticuerpos anti-siglec-8 y corticosteroides. |
| WO2021081411A1 (en) * | 2019-10-24 | 2021-04-29 | Allakos Inc. | Methods and compositions for treating irritable bowel syndrome and functional dyspepsia |
| AU2021365008A1 (en) * | 2020-10-22 | 2023-06-08 | Allakos Inc. | Anti-siglec-8 antibody formulations |
| EP4469601A1 (en) * | 2022-01-24 | 2024-12-04 | Children's Hospital Medical Center | Methods of treating eosinophilic colitis |
| US20240225536A9 (en) * | 2022-10-21 | 2024-07-11 | Case Western Reserve University | Radiomics signatures for pathologic characterization of strictures on mr and ct enterography |
| IL323497A (en) * | 2023-03-27 | 2025-11-01 | Regeneron Pharma | Methods for treating eosinophilic gastroenteritis by administering an IL-4R antagonist |
| CN117187180B (zh) * | 2023-11-03 | 2024-01-26 | 四川大学 | 一种Th17细胞及其培养方法和应用及其诱导液 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7745421B2 (en) * | 2004-05-25 | 2010-06-29 | The Johns Hopkins University | Methods and compositions for treating diseases and disorders associated with Siglec-8 expressing cells |
| AU2008255352B2 (en) * | 2007-05-31 | 2014-05-22 | Genmab A/S | Stable IgG4 antibodies |
| CA2745439C (en) * | 2008-12-03 | 2019-10-15 | Genmab A/S | Antibody variants having modifications in the constant region |
| EP2465873A1 (en) * | 2010-12-16 | 2012-06-20 | Deutsches Rheuma-Forschungszentrum Berlin | Eosinophils as a therapeutic target |
| AU2012272559C1 (en) * | 2011-06-23 | 2017-04-20 | Children's Hospital Medical Center | Molecular diagnostic panel of eosinophilic gastrointestinal disorders |
| US9260756B2 (en) * | 2012-02-24 | 2016-02-16 | Children's Hospital Medical Center | Esophageal microRNA expression profiles in eosinophilic esophagitis |
| TWI634900B (zh) * | 2013-07-11 | 2018-09-11 | 再生元醫藥公司 | 藉由投與ｉｌ－４ｒ抑制劑治療嗜酸性食道炎的方法 |
| KR20210125114A (ko) * | 2013-12-09 | 2021-10-15 | 알라코스 인크. | 항-Siglec-8 항체 및 그의 사용 방법 |
| JP6825909B2 (ja) * | 2014-02-28 | 2021-02-03 | アラコス インコーポレイテッド | シグレック−８関連疾患を処置するための方法および組成物 |
| HK1254432A1 (zh) * | 2015-06-17 | 2019-07-19 | Allakos Inc. | 用於治疗纤维性疾病的方法和组合物 |
| US10604577B2 (en) * | 2015-10-22 | 2020-03-31 | Allakos Inc. | Methods and compositions for treating systemic mastocytosis |
| BR112019022912A2 (pt) * | 2017-05-05 | 2020-05-26 | Allakos Inc. | Métodos e composições para tratar doenças oculares alérgicas |
| GB201820174D0 (en) * | 2018-12-11 | 2019-01-23 | Nordic Semiconductor Asa | Radio communication |
| BR112021015009A2 (pt) * | 2019-02-15 | 2021-10-05 | Allakos Inc. | Métodos e composições para o tratamento da gastrite mastocística, esofagite mastocística, enterite mastocística, duodenite mastocística e/ou gastroenterite mastocística |
| JP2022535400A (ja) * | 2019-06-07 | 2022-08-08 | エピセリオン サイエンス バイオテック，エセ．エレ． | 好酸球性消化管疾患の処置のためのイルソグラジン |
| MX2022001403A (es) * | 2019-08-02 | 2022-03-25 | Allakos Inc | Metodos de administracion de anticuerpos anti-siglec-8 y corticosteroides. |
| WO2021081411A1 (en) * | 2019-10-24 | 2021-04-29 | Allakos Inc. | Methods and compositions for treating irritable bowel syndrome and functional dyspepsia |
| JP2023511279A (ja) * | 2020-01-13 | 2023-03-17 | フルーエント バイオサイエンシーズ インコーポレイテッド | 単一細胞シーケンシング |
| AU2021365008A1 (en) * | 2020-10-22 | 2023-06-08 | Allakos Inc. | Anti-siglec-8 antibody formulations |
| US20240254441A1 (en) * | 2021-06-04 | 2024-08-01 | Kirin Holdings Kabushiki Kaisha | Cell composition, method for producing cell composition, and pharmaceutical composition containing cell composition |
| KR20250007535A (ko) * | 2022-04-22 | 2025-01-14 | 인히브릭스 바이오사이언스, 인크. | Siglec-8 결합 단백질 및 그 용도 |
-
2018
- 2018-05-04 MX MX2019013136A patent/MX2019013136A/es unknown
- 2018-05-04 AU AU2018263937A patent/AU2018263937A1/en not_active Abandoned
- 2018-05-04 SG SG10202112259VA patent/SG10202112259VA/en unknown
- 2018-05-04 US US16/610,429 patent/US20200270344A1/en not_active Abandoned
- 2018-05-04 EP EP18795249.4A patent/EP3618872A4/en active Pending
- 2018-05-04 KR KR1020197035570A patent/KR20200015511A/ko not_active Ceased
- 2018-05-04 WO PCT/US2018/031231 patent/WO2018204871A1/en not_active Ceased
- 2018-05-04 IL IL270304A patent/IL270304B2/en unknown
- 2018-05-04 CA CA3062430A patent/CA3062430A1/en active Pending
- 2018-05-04 CN CN201880044727.6A patent/CN111246880A/zh active Pending
- 2018-05-04 JP JP2019560756A patent/JP7346304B2/ja active Active
- 2018-05-04 SG SG11201910206Q patent/SG11201910206QA/en unknown
- 2018-05-04 BR BR112019022957A patent/BR112019022957A2/pt not_active Application Discontinuation
-
2019
- 2019-11-06 ZA ZA2019/07372A patent/ZA201907372B/en unknown
-
2023
- 2023-05-15 JP JP2023080140A patent/JP2023099232A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7579227B2 (ja) | 瘻孔を伴うクローン病の治療用ベドリズマブ | |
| JP5795167B2 (ja) | 疾患治療剤 | |
| JP5604311B2 (ja) | 疾患治療剤 | |
| CN111068062B (zh) | 治疗白介素-6相关疾病的方法 | |
| JP2018535648A5 (enExample) | ||
| KR102167261B1 (ko) | 관절염 치료 | |
| JP2022520105A5 (enExample) | ||
| Malviya et al. | Biological therapies for rheumatoid arthritis: progress to date | |
| JP2020518638A5 (enExample) | ||
| JP2022137024A (ja) | 移植片対宿主病の処置または予防の方法 | |
| CN112480259B (zh) | 抗tnfr2抗体及其用途 | |
| US7611702B2 (en) | TNF-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapy | |
| JP2018533569A5 (enExample) | ||
| JP2024069230A5 (enExample) | ||
| WO2017058771A1 (en) | Antibodies that bind human cannabinoid 1 (cb1) recetor | |
| JP2019508448A (ja) | 移植片対宿主病予防の方法 | |
| JP2019508448A5 (enExample) | ||
| Danese et al. | Biological Therapies for Inflammatory Bowel Disease: Research DrivesClinics | |
| JP2022542472A5 (enExample) | ||
| US20130004516A1 (en) | Drug for inflammatory bowel disease | |
| TW202114663A (zh) | EZH2抑制劑與含有TGF-β受體的融合蛋白聯合在製備治療腫瘤的藥物中的用途 | |
| JP2026516281A (ja) | Ｃｄ２０発現ｂ細胞癌の治療方法 | |
| WO2017070567A1 (en) | Klebsiella pneumoniae antibodies and methods to treat klebsiella pneumoniae infections | |
| WO2023186113A1 (zh) | 靶向pd-l1和cd40的抗原结合蛋白及其制备和应用 | |
| WO2023196153A1 (en) | Methods for treating cancer, an infectious disease or an infection using a combination of a tigit antagonist, a pd-1 antagonist, and a vegf antagonist |